Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2024 earnings results
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2024 earnings results today.
Reported sales increased 5.3% year-over-year to $22.5 billion. Operational sales growth was 6.7%.
Net earnings decreased 17% to $3.4 billion, or $1.41 per share, compared to last year. Adjusted EPS decreased 10.9% to $2.04.
Revenue surpassed projections while earnings came in line with estimates.
For full-year 2025, the company expects reported sales of $89.2-90.0 billion and adjusted EPS of $10.50-10.70.
The stock stayed red in premarket hours on Wednesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
What Starbucks’ ongoing restructuring means for customers and investors
Starbucks Corporation (NASDAQ: SBUX) has launched an extensive restructuring to streamline operations and optimize customer experience. While navigating a difficult operating environment, the coffee giant is working to revive its
Dollar Tree (DLTR) 4Q24 earnings: Family Dollar sale takes center stage in quarterly report
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) were up over 4% on Wednesday following the announcement of the company’s fourth quarter 2024 earnings results. The top and bottom line numbers
Key metrics from Chewy’s (CHWY) Q4 2024 earnings results
Chewy, Inc. (NYSE: CHWY) reported its fourth quarter 2024 earnings results today. Net sales of $3.25 billion were up 14.9% year-over-year. Net income fell 29% to $22.8 million, or $0.05
